Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1

Eidt LM, 2004, Breve história da hanseníase: sua expansão do mundo para as Américas, o Brasil e o Rio Grande do Sul e sua trajetória na saúde pública brasileira, Saúde Soc, 13, 76

Cavaliere IAL, 2011, Isolamento social, sociabilidades e redes sociais de cuidados, Physis, 21, 491, 10.1590/S0103-73312011000200009

Cunha VS, 2010, solated 'like us' or isolated 'among us'?: the controversy within the National Academy of Medicine over compulsory isolation of leprosy sufferers, Hist Cienc Saude Manguinhos, 17, 939

Opromolla PA, 2005, Terminology related to Hansen's disease, An Bras Dermatol, 80, 293, 10.1590/S0365-05962005000300011

2012, Global leprosy situation, 2012, Wkly Epidemiol Rec, 87, 317

1991

Talhari S, 2012, Hansen's disease: a vanishing disease?, Mem Inst Oswaldo Cruz, 107, 13, 10.1590/S0074-02762012000900003

Penna MLF, 2008, The influence of increased access to basic healthcare on the trends in Hansen's disease detection rate in Brazil from 1980 to 2006, Rev Soc Bras Med Trop, 41, 6

Barbieri CL, 2009, Leprosy in children and adolescents: bibliographical review and current situation in Brazil. Pediatria (São Paulo), Pediatria (São Paulo), 31, 281

Ignotti E, 2004, Aplicação de métodos de estimativa da prevalência de hanseníase no Estado de Mato Grosso, Rev Bras Epidemiol, 7, 155, 10.1590/S1415-790X2004000200005

Goulart IB, 2002, Grau de incapacidade: indicador de prevalência oculta e qualidade do programa de controle da hanseníase em um centro de saúde-escola no município de Uberlândia - MG, Hansen int, 27, 5, 10.47878/hi.2002.v27.35315

da Cunha MD, 2007, Os indicadores da hanseníase e as estratégias de eliminação da doença, em município endêmico do Estado do Rio de Janeiro, Brasil, Cad Saude Publica, 23, 1187, 10.1590/S0102-311X2007000500020

Rees RJW, 1994, The microbiology of leprosy, 2nd ed, 49

Nolte FS, 1995, Mycobacterium, 6th ed, 400

Shepard CC, 1965, Temperature optimum of Mycobacterium leprae in mice, J Bacteriol, 90, 1271, 10.1128/JB.90.5.1271-1275.1965

Hastings RC, 1968, Bacterial density in the skin in lepromatous leprosy as related to temperature, Lepr Rev, 39, 71

Desikan KV, 1977, Viability of Mycobacterium leprae outside the human body, Lepr Rev, 48, 231

Draper P, 1983, The bacteriology of Mycobacterium leprae, Tubercle, 64, 43, 10.1016/0041-3879(83)90050-8

Hirata T, 1985, Electron microscopic observations of cell wall and cytoplasmic membrane in murine and human leprosy bacilli, Int J Lepr Other Mycobact Dis, 53, 433

Cole ST, 2001, Massive gene decay in the leprosy bacillus, Nature, 409, 1007, 10.1038/35059006

Vissa VD, 2001, The genome of Mycobacterium leprae: a minimal mycobacterial gene set, Genome Biol, 2, 10.1186/gb-2001-2-8-reviews1023

Deps PD, 2007, Detection of Mycobacterium leprae infection in wild nine-banded armadillos (Dasypus novemcinctus) using the rapid ML Flow test, Rev Soc Bras Med Trop, 40, 86, 10.1590/S0037-86822007000100019

Donham KJ, 1977, Spontaneous leprosy-like disease in a chimpanzee, J Infect Dis, 136, 132, 10.1093/infdis/136.1.132

Walsh GP, 1981, Leprosy-a zoonosis, Lepr Rev, 52, 77

Kazda J, 1986, Isolation of environment-derived Mycobacterium leprae from soil in Bombay, Lepr Rev, 57, 201

Matsuoka M, 1999, Mycobacterium leprae DNA in daily using water as a possible source of leprosy infection, Indian J Lepr, 71, 61

Bona SH, 1985, Bacilos álcool-ácido resistentes no Culex fatigans, An Bras Dermatol, 60, 163

Shepard CC, 1962, The nasal excretion of Mycobacterium leprae in leprosy, Int J Lepr, 30, 10

Martins AC, 2010, Estudo da mucosa nasal de contatos de hanseníase, com positividade para o antígeno glicolipídio fenólico 1, Braz J Otorhinolaryngol, 76, 579, 10.1590/S1808-86942010000500008

Job CK, 1990, Nasal mucosa and abraded skin are the two routes of entry of Mycobacterium leprae, Star, 49, 1

Ghorpade A, 2002, Inoculation (tattoo) leprosy: a report of 31 cases, J Eur Acad Dermatol Venereol, 16, 494, 10.1046/j.1468-3083.2002.00548.x

Santos AR, 2001, Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy, Mem Inst Oswaldo Cruz, 96, 1129, 10.1590/S0074-02762001000800017

Melsom R, 1981, IgA and IgM antibodies against Mycobacterium leprae in cord sera and in patients with leprosy: an indicator of intrauterine infection in leprosy, Scand J Immunol, 14, 343, 10.1111/j.1365-3083.1981.tb00574.x

Pedley JC, 1967, The presence of M. leprae in human milk, Lepr Rev, 38, 239

Klatser PR, 1993, Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic, Microbiol, 31, 2947

Hatta M, 1995, Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia, Trans R Soc Trop Med Hyg, 89, 381, 10.1016/0035-9203(95)90018-7

van Beers SM, 1996, The epidemiology of Mycobacterium leprae: recent insight, FEMS Microbiol Lett, 136, 221, 10.1016/0378-1097(95)00505-6

Cree IA, 1998, Leprosy transmission and mucosal immunity: towards eradication?, Lepr Rev, 69, 112

Pattyn SR, 1993, Detection of Mycobacterium leprae by the polymerase chain reaction in nasal swabs of leprosy patients and their contacts, Int J Lepr Other Mycobact Dis, 61, 389

van Beers SM, 1994, An epidemiological study of leprosy infection by serology and polymerase chain reaction, Int J Lepr Other Mycobact Dis, 62, 1

Ramaprasad P, 1997, Transmission and protection in leprosy: indications of the role of mucosal immunity, Lepr Rev, 68, 301

Izumi S, 1999, An epidemiological study on Mycobacterium leprae infection and prevalence of leprosy in endemic villages by molecular biological technique, Indian J Lepr, 71, 37

Patrocínio LG, 2005, Detection of Mycobacterium leprae in nasal mucosa biopsies by the polymerase chain reaction, FEMS Immunol Med Microbiol, 44, 311, 10.1016/j.femsim.2005.01.002

Job CK, 2008, Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR, Am J Trop Med Hyg, 78, 518, 10.4269/ajtmh.2008.78.518

Baumgart KW, 1993, Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies, Trans R Soc Trop Med Hyg, 87, 412, 10.1016/0035-9203(93)90016-J

Brasil MTLRF, 1998, Aplicação do teste Elisa anti-PGL-1 em localidade com alta edemicidade de hanseníase, na Região Norte do Estado de São Paulo, Hansen Int, 23, 35, 10.47878/hi.1998.v23.36463

de Wit MY, 1993, Polymerase chain reaction for detection of Mycobacterium leprae in nasal swab specimens, J Clin Microbiol, 31, 502, 10.1128/JCM.31.3.502-506.1993

Fine PE, 1997, Household and dwelling contact as risk factors for leprosy in northern Malawi, Am J Epidemiol, 146, 91, 10.1093/oxfordjournals.aje.a009195

Moet FJ, 2004, Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions, Lepr Rev, 75, 310, 10.47276/lr.75.4.310

Mira MT, 2011, Aspectos genéticos da suscetibilidade do hospedeiro à hanseníase, Salud cienc, 18, 138

Prevedello FC, 2007, Leprosy: a genetic disease?, An Bras Dermatol, 82, 451

Mira MT, 2004, Susceptibility to leprosy is associated with PARK2 and PACRG, Nature, 427, 636, 10.1038/nature02326

Alcais A, 2007, Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy, Nat Genet, 39, 517, 10.1038/ng2000

Cooke GS, 2001, Genetics of susceptibility to human infectious disease, Nat Rev Genet, 2, 967, 10.1038/35103577

Roy S, 1997, Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy, J Infect Dis, 176, 530, 10.1086/517282

Moraes MO, 2004, Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy, Genes Immun, 5, 592, 10.1038/sj.gene.6364122

Malhotra D, 2005, IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy, Hum Genet, 118, 295, 10.1007/s00439-005-0042-8

Santos AR, 2002, Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy, J Infect Dis, 186, 1687, 10.1086/345366

Shaw MA, 2001, Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes, Genes Immun, 2, 196, 10.1038/sj.gene.6363754

Franceschi DS, 2009, Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil, Int J Infect Dis, 13, 493, 10.1016/j.ijid.2008.08.019

Sarno EN, 2000, Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF?, Lepr Rev, 71, S154

Zhang FR, 2009, Genomewide association study of leprosy, N Engl J Med, 361, 2609, 10.1056/NEJMoa0903753

Meisner SJ, 2001, Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy in west Africans, Am J Trop Med Hyg, 65, 733, 10.4269/ajtmh.2001.65.733

Siddiqui MR, 2001, A major susceptibility locus for leprosy in India maps to chromosome 10p13, Nat Genet, 27, 439, 10.1038/86958

Roy S, 1999, Association of vitamin D receptor genotype with leprosy type, J Infect Dis, 179, 187, 10.1086/314536

Bochud PY, 2008, Tolllike receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy, J Infect Dis, 197, 253, 10.1086/524688

Scollard DM, 2006, The continuing challenges of leprosy, Clin Microbiol Rev, 19, 338, 10.1128/CMR.19.2.338-381.2006

Modlin RL, 1993, Immune regulation: learning from leprosy, Hosp Pract (Off Ed), 28, 71, 10.1080/21548331.1993.11442874

Mendonça VA, 2008, Immunology of leprosy, An Bras Dermatol, 83, 343

Oliveira MLW, 2008, The use of serology as an additional tool to support diagnosis of difficult multibacillary leprosy cases: lessons from clinical care, Rev Soc Bras Med Trop, 41, 27

Ottenhoff TH, 1994, Immunology of leprosy: lessons from and for leprosy, Int J Lepr Other Mycobact Dis, 62, 108

Van Voorhis WC, 1982, The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes, N Engl J Med, 307, 1593, 10.1056/NEJM198212233072601

Modlin RL, 1983, T lymphocyte subsets in the skin lesions of patients with leprosy, J Am Acad Dermatol, 8, 182, 10.1016/S0190-9622(83)70021-6

Narayanan RB, 1983, T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies, Clin Exp Immunol, 51, 421

Modlin RL, 1986, Suppressor T lymphocytes from lepromatous leprosy skin lesions, J Immunol, 137, 2831, 10.4049/jimmunol.137.9.2831

Modlin RL, 1988, Learning from lesions: patterns of tissue inflammation in leprosy, Proc Natl Acad Sci U S A, 85, 1213, 10.1073/pnas.85.4.1213

Sieling PA, 1993, Immunosuppressive roles for IL-10 and IL-4 in human infection: In vitro modulation of T cell responses in leprosy, J Immunol, 150, 5501, 10.4049/jimmunol.150.12.5501

Scollard DM, 1991, Inside the skin: the local immune and inflammatory milieu in leprosy, Am J Trop Med Hyg, 44, 17, 10.4269/ajtmh.1991.44.4_Part_2.TM0444P20017

Yamamura M, 1991, Defining protective responses to pathogens: cytokine profiles in leprosy lesions, Science, 254, 277, 10.1126/science.1925582

Sieling PA, 1992, T cell and cytokine patterns in leprosy skin lesions, Springer Semin Immunopathol, 13, 413, 10.1007/BF00200538

Silva CL, 1989, Tumor necrosis factor in leprosy patients, J Infect Dis, 159, 787, 10.1093/infdis/159.4.787

Warwick-Davies J, 1995, Selective deactivation of human monocyte functions by TGF-beta, J Immunol, 155, 3186, 10.4049/jimmunol.155.6.3186

Henao MI, 2006, Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis, Tuberculosis (Edinb), 86, 11, 10.1016/j.tube.2005.03.001

Hsieh CS, 1993, Development of Th1 CD4+ T-cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547, 10.1126/science.8097338

Sieling PA, 1994, Cytokine patterns at the site of mycobacterial infection, Immunobiology, 191, 378, 10.1016/S0171-2985(11)80443-2

Yamamura M, 1992, Cytokine patterns of immunologically mediated tissue damage, J Immunol, 149, 1470, 10.4049/jimmunol.149.4.1470

Foss NT, 1997, Aspectos imunológicos da hanseníase, Medicina (Ribeirão Preto), 30, 335, 10.11606/issn.2176-7262.v30i3p335-339

1953, International Congress of leprosy, Madrid; 1953, Int J Lepr, 21, 504

Rabello FE, 1936, Uma classificação clínico-epidemiológica das formas de lepra, Rev Bras Leprol, 375

Ridley DS, 1962, A classification of leprosy for research purposes, Lepr Rev, 33, 119

Ridley DS, 1966, Classification of leprosy according to immunity. A five-group system, Int J Lepr Other Mycobact Dis, 34, 255

1982, Chemotherapy of leprosy for control programmes, World Health Organ Tech Rep Ser, 675, 1

1988, World Health Organ Tech Rep, Ser, 768, 1

Contin LA, 2011, Use of the ML-Flow test as a tool in classifying and treating leprosy, An Bras Dermatol, 86, 91

Bührer-Sékula S, 2003, Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy, J Clin Microbiol, 41, 1991, 10.1128/JCM.41.5.1991-1995.2003

Nery JAC, 2006, Contribuição ao diagnóstico e manejo dos estados reacionais: Uma abordagem prática, An bras dermatol, 81, 367, 10.1590/S0365-05962006000400010

Douglas JT, 2004, Prospective study of serological conversion as a risk factor for development of leprosy among household contacts, Clin Diagn Lab Immunol, 11, 897, 10.1128/CDLI.11.5.897-900.2004

Noordeen SK, 1977, Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 8 1/2 years follow-up, Lepr India, 49, 504

Meneses S, 1988, Lepra visceral: presentacion de dos casos y revision de la literatura, Dermatol Venez, 26, 79

Kahawita IP, 2008, Leprosy type 1 reactions and erythema nodosum leprosum, An Bras Dermatol, 83, 75, 10.1590/S0365-05962008000100010

Monteiro R, 2012, Lucio's phenomenon: another case reported in Brazil, An Bras Dermatol, 87, 296, 10.1590/S0365-05962012000200017

Garbino JA, 2007, O paciente com suspeita de hanseníase primariamente neural / The patient with suspicion of primarily neural leprosy, Hansen Int, 32, 203, 10.47878/hi.2007.v32.36306

Martins CF, 1995, Exame palpatório de nervos periféricos (espessados na hanseníase) e suas vias anatômicas, An Bras Dermatol, 70, 247

Agrawal A, 2005, Neurological manifestations of Hansen's disease and their management, Clin Neurol Neurosurg, 107, 445, 10.1016/j.clineuro.2005.03.007

2008, 3. ed.

Lehman LF, 1997

Gopinath DV, 2004, A clinical study of the involvement of cranial nerves in leprosy, Indian J Lepr, 76, 1

Lewallen S, 2000, Progression of eye disease in "cured" leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs, Br J Ophthalmol, 84, 817, 10.1136/bjo.84.8.817

Mattar R, Lesão dos nervos periféricos

Klioze AM, 2000, Visceral leprosy, Int J Dermatol, 39, 641, 10.1046/j.1365-4362.2000.00860.x

de Abreu MA, 2006, The oral mucosa in leprosy: a clinical and histopathological study, Braz J Otorhinolaryngol, 72, 312, 10.1016/S1808-8694(15)30962-9

Morgado de Abreu MA, 2010, Presence of oral lesions in leprosy patients does not imply involvement by Mycobacterium leprae, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, 328, 10.1016/j.tripleo.2009.11.020

de Abreu MA, 2007, The oral mucosa in paucibacillary leprosy: a clinical and histopathological study, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103, e48, 10.1016/j.tripleo.2006.10.002

Leal AMO, 1997, Endocrine changes in leprosy, Medicina (Ribeirão Preto), 340